Vandana Singh
·
June 16, 2025
Benzinga
Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access without insurance barriers.
read more
April 14, 2025
Financial Times
June 6, 2025
Bloomberg
May 15, 2025